Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/10230/37010
dc.contributor.author | Piñero González, Janet, 1977- |
---|---|
dc.contributor.author | Furlong, Laura I., 1971- |
dc.contributor.author | Sanz, Ferran |
dc.date | 2018 |
dc.identifier.citation | Piñero J, Furlong LI, Sanz F. In silico models in drug development: where we are. Curr Opin Pharmacol. 2018; 42:111-121. DOI 10.1016/j.coph.2018.08.007 |
dc.identifier.citation | 1471-4892 |
dc.identifier.citation | http://dx.doi.org/10.1016/j.coph.2018.08.007 |
dc.identifier.uri | http://hdl.handle.net/10230/37010 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/681002 |
dc.rights | info:eu-repo/semantics/embargoedAccess |
dc.rights | © Elsevier http://dx.doi.org/10.1016/j.coph.2018.08.007 |
dc.subject | Dades -- Anàlisi |
dc.subject | Medicaments -- Administració |
dc.title | In silico models in drug development: where we are |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract | |
dc.description.abstract |